Showing 40,681 - 40,700 results of 63,008 for search '(( 09 ((0 decrease) OR (a decrease)) ) OR ( 20 ((mean decrease) OR (we decrease)) ))', query time: 1.37s Refine Results
  1. 40681

    Data_Sheet_1_Associations Between Nutritional Deficits and Physical Performance in Community-Dwelling Older Adults.docx by Wan-Hsuan Lu (4978271)

    Published 2021
    “…Baseline nutritional deficits were defined as plasma 25 hydroxyvitamin D <20 ng/ml, plasma homocysteine >14 μmol/L, or erythrocyte omega-3 PUFA index ≤ 4.87% (lower quartile). …”
  2. 40682

    Table_3_Cardiac Shock Wave Therapy in Coronary Artery Disease: A Systematic Review and Meta-Analysis.DOCX by Quan Qiu (7008749)

    Published 2022
    “…Seven studies with 312 patients reported left ventricular internal diameter in diastole (LVIDd) were markedly decreased in the CSWT group compared to the control group (WMD −1.81, 95% CI −3.23 to −0.39, p = 0.012, I<sup>2</sup> = 20.3%). …”
  3. 40683

    Table_1_Cardiac Shock Wave Therapy in Coronary Artery Disease: A Systematic Review and Meta-Analysis.DOCX by Quan Qiu (7008749)

    Published 2022
    “…Seven studies with 312 patients reported left ventricular internal diameter in diastole (LVIDd) were markedly decreased in the CSWT group compared to the control group (WMD −1.81, 95% CI −3.23 to −0.39, p = 0.012, I<sup>2</sup> = 20.3%). …”
  4. 40684

    Table_2_Cardiac Shock Wave Therapy in Coronary Artery Disease: A Systematic Review and Meta-Analysis.DOCX by Quan Qiu (7008749)

    Published 2022
    “…Seven studies with 312 patients reported left ventricular internal diameter in diastole (LVIDd) were markedly decreased in the CSWT group compared to the control group (WMD −1.81, 95% CI −3.23 to −0.39, p = 0.012, I<sup>2</sup> = 20.3%). …”
  5. 40685

    Supplementary Material for: Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Clinical Practice of Single Center: Three-Year Outcomes by Choovuthayakorn J. (10496261)

    Published 2021
    “…However, when initial VA was 20/40 and better, a non-statistically significant change in mean VA by +2.0, −3.5, and −3.6 letters were noted at the same time point (<i>p</i> value between 0.078 and 0.273). …”
  6. 40686
  7. 40687
  8. 40688
  9. 40689

    Body composition, blood glucose, and serum factors in C57BL/6 mice following 21 weeks of diet treatment. by Alison E. Harvey (560954)

    Published 2014
    “…<p>Calorie restriction (CR) decreased A, body weight (reported up to 20 weeks on diets, before tumor cell injection); B, percent body fat (at 21 weeks on diet); and C, fasting blood glucose (at 21 weeks on diet) relative to CON diet (n = 15/group). …”
  10. 40690

    Overexpression of <i>hsf-1</i><sup><i>neuro</i></sup> in neurons activates a fat remodeling transcriptional program that resembles one activated by worms acclimated at 25°C. by Laetitia Chauve (8600553)

    Published 2021
    “…<b>(I)</b> Overlaid GFP fluorescence and DIC images taken at 20× magnification. <b>(J)</b> Average GFP fluorescence intensity driven by the <i>fat-6</i> promoter is decreased by 51% in <i>hsf-1</i><sup><i>neuro</i></sup> <i># 2</i> (MOC299) compared to controls (BX115, compare mean intensity of 36.6 +/− 2.5 versus 18.8 +/−0.99). …”
  11. 40691

    Table_1_Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents With Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials.... by Ying Liu (18461)

    Published 2022
    “…Results suggested that metformin significantly decreased the HbA1c level at 12 months (mean difference [MD])=-0.50, 95% confidence interval [CI]=-0.61 to -0.39, P < 0.01); BMI (kg/m<sup>2</sup>) at 3 months (MD=-1.05, 95%CI=-2.05 to -0.05, P=0.04); BMI z-score at 6 months (MD=-0.10, 95%CI=-0.14 to -0.06, P<0.01); and TIDD at 3 (MD=-0.13, 95%CI=-0.20 to -0.06, P<0.01), 6 (MD=-0.18, 95%CI=-0.25 to -0.11, P<0.01), and 12 (MD=-0.42, 95%CI=-0.49 to -0.35, P<0.01) months but significantly increased the risk of hypoglycemia events (risk ratio [RR]=3.13, 95%CI=1.05 to 9.32, P=0.04) and GIAEs (RR=1.64, 95%CI=1.28 to 2.10, P<0.01). …”
  12. 40692

    Table_2_Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents With Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials.... by Ying Liu (18461)

    Published 2022
    “…Results suggested that metformin significantly decreased the HbA1c level at 12 months (mean difference [MD])=-0.50, 95% confidence interval [CI]=-0.61 to -0.39, P < 0.01); BMI (kg/m<sup>2</sup>) at 3 months (MD=-1.05, 95%CI=-2.05 to -0.05, P=0.04); BMI z-score at 6 months (MD=-0.10, 95%CI=-0.14 to -0.06, P<0.01); and TIDD at 3 (MD=-0.13, 95%CI=-0.20 to -0.06, P<0.01), 6 (MD=-0.18, 95%CI=-0.25 to -0.11, P<0.01), and 12 (MD=-0.42, 95%CI=-0.49 to -0.35, P<0.01) months but significantly increased the risk of hypoglycemia events (risk ratio [RR]=3.13, 95%CI=1.05 to 9.32, P=0.04) and GIAEs (RR=1.64, 95%CI=1.28 to 2.10, P<0.01). …”
  13. 40693
  14. 40694
  15. 40695
  16. 40696
  17. 40697
  18. 40698
  19. 40699

    Prevention of Obesity and Hyperlipidemia by Heptamethoxyflavone in High-fat Diet-induced Rats by Konglong Feng (6384134)

    Published 2019
    “…The supplementation of HMF not only significantly decreased body weight gain (HFD, 336.50 ± 18.84 g; LHMF, 309.43 ± 20.74 g; MHMF, 296.83 ± 13.88 g; HHMF, 265.71 ± 19.09 g; respectively, <i>p</i> < 0.05) and adipose tissues weight (<i>p</i> < 0.05), but also markedly lowered serum levels of total cholesterol, triacylglycerol, and low-density lipoprotein cholesterol (<i>p</i> < 0.05) in the sixth week in a dose-dependent manner compared with the HFD group. …”
  20. 40700